In a groundbreaking development for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), the Phase 3 SEQUOIA-HCM trial has demonstrated that
In a groundbreaking analysis of the STEPHFpEF programme, researchers have discovered that semaglutide, a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA),
In a thought-provoking presentation, Dr. Milton Packer, a renowned expert in the field of cardiology, shed light on the groundbreaking
Professor Mark Petrie from the University of Glasgow and Glasgow Royal Infirmary presented an overview of the future directions and
In a session presented by Dr Felix Mahfoud MD Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge,
The Late Breaking Science Session at the European Society of Cardiology (ESC) Congress 2020 – The Digital Experience on Monday
The Hot Line Session at the European Society of Cardiology (ESC) Congress 2020 – The Digital Experience on Monday 31st
This session was presented by multiple presenters on Sunday 30th August 2020 at the ESC Congress 2020 -The Digital Experience.
This paper was presented by Dr Ester Anne Kringeland MD from the University of Bergen – Bergen – Norway on
This paper was presented by Dr Nadia Bonekamp MD from the 1University Medical Center Utrecht, Department of Vascular Medicine –